Primetime for more powerful CRISPR tech

Latest articles

Top 10 heath gadgets to live longer and healthier

Top ten health gadgets for the longevity enthusiasts in your life. As the holiday season kicks off with Thanksgiving this year, Christmas is right around...

Eliminating senescent cells in fat can alleviate signs of diabetes

Deleting dysfunctional cells could lead to game-changing treatments for diabetes and other metabolic diseases. Eliminating old, dysfunctional cells in human fat also alleviates signs of...

Longevica: bridging the gap between longevity science and consumers

Longevica CEO sheds further light on work to develop an “open research platform” to drive both longevity science and commercialisation. Following yesterday’s $2.5 million funding...

Longevity Science Summit: care of aging population talks continue

Our dive into Longevity Week's Science Summit continues... Last week, Longevity.Technology was lucky enough to attend Longevity Forum's Science Summit at Oxford's Oriel College, part...

Most read

New supplement slows aging and promotes weight loss

Sugar-proof your way to a longer life. Reducing AGEs to slow aging and increase weight loss – how one supplement is fighting the war...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Resveratrol – the small molecule with big antiaging ideas

When it comes to antiaging molecules, we can learn a thing or two from plants. As so often in natural world, plants have a few...

Editor's picks

Top 10 heath gadgets to live longer and healthier

Top ten health gadgets for the longevity enthusiasts in your life. As the holiday season kicks off with Thanksgiving this year, Christmas is right around...

Eliminating senescent cells in fat can alleviate signs of diabetes

Deleting dysfunctional cells could lead to game-changing treatments for diabetes and other metabolic diseases. Eliminating old, dysfunctional cells in human fat also alleviates signs of...

Longevica: bridging the gap between longevity science and consumers

Longevica CEO sheds further light on work to develop an “open research platform” to drive both longevity science and commercialisation. Following yesterday’s $2.5 million funding...

Click the globe for translations.

Researchers have developed a novel and more powerful form of CRISPR that offers the possibility to correct most disease-causing genetic variations in DNA  – new hope for the treatment of age-related disorders?

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and CRISPR-associated (Cas) were discovered as components of bacterial adaptive immunity in the ‘80s; however, their potential applications have not been made clear until last decade. CRISPR-Cas9 is currently the most widely used genome editing method. It is an excellent and reliable tool to make targeted changes to the genome of living cells, opening a new era in genetic engineering and revolutionising the way we approach the treatment of numerous diseases, including age-related disorders [1].

As we described in a previous article at Longevity.Technology, research led by David Liu at the Broad Institute of MIT and Harvard has led to the recent development of a new more powerful form of this technology (which they called “prime editing”) that offers the possibility of efficient and reliable introduction of precise alterations in the gene without causing double-strand breaks in the DNA double helix [2].

By increasing the range of genomic changes that can be introduced, this technology has expanded drastically the number of diseases that can be treated using genome editing, offering the potential to correct 89% of known disease-causing genetic variations in DNA. Prime editors also make genome editing in non-dividing cells such as neurons and muscle cells, possible. Thus, the treatment of neurodegenerative or muscle disorders – which are often associated with aging – has become possible [2].

The inventors have applied for a patent securing the exclusive use of this technology for the development of human therapeutics by Prime Medicine – a company co-founded by Liu. However, the non-commercial use of prime editing is freely available to academic and non-profit researchers [3].

Companies, including Editas Medicine, Shape Therapeutics, and CRISPR Therapeutics, are already testing the potential use of first-generation CRISPR technologies for the treatment of certain diseases, such as sickle cell anaemia [3]. However, age-related disorders and other more complex diseases would be almost impossible to cure with these generation 1 approaches; prime editing and Prime Medicine now provide new levels of opportunity for discovery and potential licensing opportunities for Liu’s Prime Medicine.

[1] https://ghr.nlm.nih.gov/primer/genomicresearch/genomeediting

[2] https://www.nature.com/articles/s41586-019-1711-4

[3] http://bit.ly/2Z864Lc

Image credit: Elpisterra / Shutterstock
Christos Evangelou
Since the completion of his undergraduate and doctoral studies in Molecular Biosciences, Christos has been working in the medical communications industry, driven by his passion for communicating sciences. Apart from helping researchers to publish their studies, Christos writes articles related to sciences and medicine.

Most popular

New supplement slows aging and promotes weight loss

Sugar-proof your way to a longer life. Reducing AGEs to slow aging and increase weight loss – how one supplement is fighting the war...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Resveratrol – the small molecule with big antiaging ideas

When it comes to antiaging molecules, we can learn a thing or two from plants. As so often in natural world, plants have a few...

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

Related articles

Eliminating senescent cells in fat can alleviate signs of diabetes

Deleting dysfunctional cells could lead to game-changing treatments for diabetes and other metabolic diseases. Eliminating old, dysfunctional cells in human fat also alleviates signs of...

Longevica: bridging the gap between longevity science and consumers

Longevica CEO sheds further light on work to develop an “open research platform” to drive both longevity science and commercialisation. Following yesterday’s $2.5 million funding...

Young blood: discover the possibilities of plasma based therapy

The evolution of plasma-based therapeutics is accelerating – our FREE report cuts through the young blood hype for the lowdown on the latest therapies. Our...

Longevica raises $2.5 million for open research platform

$2.5m in funding to support longevity research platform and study to accelerate the discovery of life extension mechanisms, launching in 2022. Longevica, a life science...

Fountain’s $15m to “restore youthful resilience to cells”

Longevity funding: Eli Lilly and R42 Group join the party as Khosla-backed biopharma brings total Series A financing to $26 million. Longevity biopharma Fountain Therapeutics...

    Subscribe to our newsletter